Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
4,543,606 results
  • Everolimus: Longer-term CERTITUDE. [Editorial]
    Liver Transpl 2019Mousa OY, Keaveny AP
  • The approval in 2013 by the Federal Drug Administration of everolimus [EVR] for use in liver transplant [LT] recipients was the l arrival of a "new kid on the block" in immunosuppression [IS] therapy. While sirolimus, another mammalian target of rapamycin [mTOR] inhibitor had been used off-label for many years prior to the approval of EVR, the latter's shorter terminal half-life and quicker time …
New Search Next